Prognosis of Patients With Compete Left Bundle Branch Block

  • End date
    Dec 31, 2025
  • participants needed
  • sponsor
    Chinese Academy of Medical Sciences, Fuwai Hospital
Updated on 21 January 2021
left bundle branch block
cardiac resynchronization therapy


The investigators sought to evaluate the morphological and functional changes, risk stratification and prognosis of patients of participants with compete left bundle branch block (CLBBB).

The conduction of this study was largely due to the increased clinical requirement, which reflected the increased awareness among physicians of heart failure due to asynchronous cardiac function caused by CLBBB. The investigators also aim to figure out the time point or CMR parameters for cardiac resynchronization therapy in patients with CLBBB.


The effect of cardiac resynchronization therapy (CRT) for heart failure patients was heterogeneous. Candidate selection was important before intervention. The underlying mechanical dyssynchrony of left ventricular bundle branch block was insufficiently descripted. Earlier study of investigators found novel imaging methods such as cardiovascular magnetic resonance imaging including T1 Mapping and feature tracking imaging can provide more detailed information about regional and global LV function in patients. While the role of new cardiac MR imaging techniques in predicting CRT responses, especially in LBBB patients, is still insufficient. Z Chen et al used T1 mapping technique to quantitatively assess the diffuse fibrosis burden of myocardial in heart failure patients. But they found focal fibrosis burden, not diffuse burden, is associated with a poor response to CRT. Other cardiac MR imaging parameters also showed potential predictors of CRT, such as 16 segment time-to-maximum radial wall thickness , scar locations and RV septal lead placement.In this study cardiovascular magnetic resonance imaging (including T1 Mapping combined with feature tracking imaging ) will be applied to follow up LV function in LBBB patients (with or without intervention) in 10 years to find out prognostic predictors and time point or CMR parameters for cardiac resynchronization therapy in patients with CLBBB.

Condition Right bundle branch block, Heart failure, Congestive Heart Failure, Heart failure, Heart disease, Heart disease, Cardiac Disease, ICD/Pacemaker Implantation, Cardiovascular Magnetic Resonance Imaging, Congestive Heart Failure, Cardiac Disease, left bundle branch block, lbbb, cardiac failure, congestive heart disease, ICD/Pacemaker Implantation
Treatment Cardiac magnetic resonance imaging
Clinical Study IdentifierNCT03096678
SponsorChinese Academy of Medical Sciences, Fuwai Hospital
Last Modified on21 January 2021


Yes No Not Sure

Inclusion Criteria

Subject is 18 years or older and able and willing to consent
The patient should present a complete left bundle branch block (LBBB) with QRS duration of >120ms
The patients should be in NYHA functional class I, II or III

Exclusion Criteria

No informed consent
Permanent atrial fibrillation, flutter or tachycardia (>100 bpm)
Right bundle branch block
Recent myocardial infarction, within 40 days prior to enrolment
Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90 days
Implanted with a LV assist device (LVAD), or has reasonable probability (per investigator's discretion) of receiving a LVAD in the next year
Severe aortic stenosis (with a valve area of <1.0 cm2 or significant valve disease expected to be operated on within study period)
Complex and uncorrected congenital heart disease
Claustrophobia or devices
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note